Alex Zhavoronkov, PhD, is a head of the Regenerative Medicine Laboratory at the Federal Clinical Research Center for Pediatric Hematology, Oncology and Immunology in and the adjunct professor of the Moscow Institute of Physics and Technology. He is also a director and trustee of the Biogerontology Research Foundation, a UK-based registered charity supporting  aging research worldwide and a director of the International Aging Research Portfolio (IARP) knowledge management project. He is the CEO or Insilico Medicine, Inc, a Baltimore-based company with research facility on the campus of the Johns Hopkins University Emerging Technology Centers. The company is focusing on signaling pathway activation analysis, drug discovery and drug repurposing for aging and age-related diseases. He also heads NeuroG, a neuroinformatics project intended to assist the elderly suffering from dementia. His primary research interests include systems biology of aging, regenerative medicine, next-generation  sequencing, molecular diagnostics and pathway analysis. He is the author of "The Ageless Generation: How advances in biomedicine will transform the global economy" (Palgrave Macmillan, 2013). 

He holds two Bachelor Degrees from Queen’ s University, a Masters in Biotechnology from Johns Hopkins University, and a PhD in Biophysics  from the Moscow State University.